Diminished cytokine signalling against bacterial components in mononuclear leucocytes from ulcerative colitis patients after leukocytapheresis

被引:22
作者
Mitsuyama, K
Suzuki, A
Matsumoto, S
Tomiyasu, N
Takaki, K
Takedatsu, H
Masuda, J
Handa, K
Harada, K
Nishida, H
Toyonaga, A
Sata, M
机构
[1] Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
[2] Kurume Univ, Sch Med, Dept Nephrol, Kurume, Fukuoka 8300011, Japan
[3] Yakult Cent Inst Microbiol Res, Kunitachi, Tokyo 186, Japan
关键词
cytokines; leukocytapheresis; microflora; signal transduction; ulcerative colitis;
D O I
10.1111/j.1365-2249.2005.02825.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infiltration by circulating inflammatory cells is a prominent local inflammatory feature of ulcerative colitis (UC). Several trials have suggested that leukocytapheresis by filtration can benefit patients with active UC. We investigated how this therapy might modulate the inflammatory response. Patients with active UC who were beginning repeated filtration leukocytapheresis were studied. Mononuclear cell preparations were obtained from blood before and after the first treatment, and expression of cytokine signalling components and the cell-proliferative response were analysed in vitro. Leukocytapheresis reduced lipopolysaccharide-induced production of proinflammatory cytokines (interleukin-1, -6, -8 and tumour necrosis factor-alpha, P < 0.05 for all) and activation of intracellular signalling components (nuclear factor-kappa B, mitogen-activated protein kinases, and signal transducer and activator of transcription-3), as well as surface expression of toll-like receptor-4 (P < 0.05) in mononuclear cells. The therapy also reduced the cell-proliferative response by mononuclear cells stimulated with sonicated bacterial preparations from autologous intestine (P < 0.05). These results indicate that activated mononuclear cells in the peripheral blood of patients with active UC are removed by leukocytapheresis and replaced by cells with a lower activation status. This replacement may partly explain the therapeutic benefit.
引用
收藏
页码:130 / 140
页数:11
相关论文
共 70 条
[31]   Mitogen-activated protein kinases and NF-κB are involved in TNF-α responses to group B streptococci [J].
Mancuso, G ;
Midiri, A ;
Beninati, C ;
Piraino, G ;
Valenti, A ;
Nicocia, G ;
Teti, D ;
Cook, T ;
Teti, G .
JOURNAL OF IMMUNOLOGY, 2002, 169 (03) :1401-1409
[32]   Imbalance production between interleukin-1β (IL-1β) and IL-1 receptor antagonist (IL-1Ra) in bronchial asthma [J].
Mao, XQ ;
Kawai, M ;
Yamashita, T ;
Enomoto, T ;
Dake, Y ;
Sasaki, S ;
Kataoka, Y ;
Fukuzumi, T ;
Endo, K ;
Sano, H ;
Aoki, T ;
Kurimoto, F ;
Adra, CN ;
Shirakawa, T ;
Hopkin, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 276 (02) :607-612
[33]  
Matsumoto A, 1999, MOL CELL BIOL, V19, P6396
[34]  
MCCARTHY DA, 1991, CLIN EXP IMMUNOL, V86, P489
[35]   MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways [J].
Medzhitov, R ;
Preston-Hurlburt, P ;
Kopp, E ;
Stadlen, A ;
Chen, CQ ;
Ghosh, S ;
Janeway, CA .
MOLECULAR CELL, 1998, 2 (02) :253-258
[36]  
MITSUYAMA K, 1994, CLIN EXP IMMUNOL, V96, P432
[37]   COLONIC MUCOSAL INTERLEUKIN-6 IN INFLAMMATORY BOWEL-DISEASE [J].
MITSUYAMA, K ;
SASAKI, E ;
TOYONAGA, A ;
IKEDA, H ;
TSURUTA, O ;
IRIE, A ;
ARIMA, N ;
ORIISHI, T ;
HARADA, K ;
FUJISAKI, K ;
SATA, M ;
TANIKAWA, K .
DIGESTION, 1991, 50 (02) :104-111
[38]   T-CELL ACTIVATION IN CROHNS-DISEASE - INCREASED LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN SERUM AND IN SUPERNATANTS OF STIMULATED PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
MUELLER, C ;
KNOFLACH, P ;
ZIELINSKI, CC .
GASTROENTEROLOGY, 1990, 98 (03) :639-646
[39]  
Nagase K, 1998, Ther Apher, V2, P120, DOI 10.1111/j.1744-9987.1998.tb00088.x
[40]   CYTOKINE PRODUCTION IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE [J].
NAKAMURA, M ;
SAITO, H ;
KASANUKI, J ;
TAMURA, Y ;
YOSHIDA, S .
GUT, 1992, 33 (07) :933-937